GETI.B

191.65

-1.01%↓

AMBEA

108.9

+0.93%↑

ARJOB

31.34

-0.89%↓

MSON.B

8.8

+0.92%↑

ATORX

3.934

+0.2%↑

GETI.B

191.65

-1.01%↓

AMBEA

108.9

+0.93%↑

ARJOB

31.34

-0.89%↓

MSON.B

8.8

+0.92%↑

ATORX

3.934

+0.2%↑

GETI.B

191.65

-1.01%↓

AMBEA

108.9

+0.93%↑

ARJOB

31.34

-0.89%↓

MSON.B

8.8

+0.92%↑

ATORX

3.934

+0.2%↑

GETI.B

191.65

-1.01%↓

AMBEA

108.9

+0.93%↑

ARJOB

31.34

-0.89%↓

MSON.B

8.8

+0.92%↑

ATORX

3.934

+0.2%↑

GETI.B

191.65

-1.01%↓

AMBEA

108.9

+0.93%↑

ARJOB

31.34

-0.89%↓

MSON.B

8.8

+0.92%↑

ATORX

3.934

+0.2%↑

Search

Vitrolife AB

Fermé

156.4 -1.51

Résumé

Variation du prix de l'action

24h

Actuel

Min

155.8

Max

161.3

Chiffres clés

By Trading Economics

Revenu

-81M

101M

Ventes

-117M

842M

P/E

Moyenne du Secteur

43.079

56.602

BPA

0.74

Rendement du dividende

0.7

Marge bénéficiaire

11.995

Employés

1,150

EBITDA

31M

256M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.70%

2.45%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

474M

21B

Ouverture précédente

157.91

Clôture précédente

156.4

Vitrolife AB Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 mai 2025, 23:40 UTC

Actions en Tendance

Stocks to Watch: UnitedHealth Group, Foot Locker, CoreWeave

14 mai 2025, 23:33 UTC

Principaux Mouvements du Marché

UnitedHealth Group Shares Fall After WSJ Reports of Investigation for Possible Medicare Fraud

14 mai 2025, 23:25 UTC

Principaux Mouvements du Marché

Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole

14 mai 2025, 23:25 UTC

Résultats

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth -- Update

14 mai 2025, 22:58 UTC

Résultats

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth

14 mai 2025, 21:35 UTC

Résultats

Cisco Systems Names Patterson as CFO, Patel as President

14 mai 2025, 23:59 UTC

Market Talk

Implications of Xero's Cost Outlook Aren't Clear -- Market Talk

14 mai 2025, 23:49 UTC

Market Talk

Xero's Cost Outlook Likely to Prompt Downgrades -- Market Talk

14 mai 2025, 23:48 UTC

Market Talk

Global Equities Roundup: Market Talk

14 mai 2025, 23:48 UTC

Market Talk

Nikkei May Decline on Profit-Taking After Recent Gains -- Market Talk

14 mai 2025, 23:47 UTC

Market Talk

Gold Gains on Possible Technical Recovery -- Market Talk

14 mai 2025, 23:34 UTC

Acquisitions, Fusions, Rachats

Agnico-Eagle Mines to Subscribe for 30M Voting Common Shares of Foran Mining in Non-Brokered Private Placement at C$3 a Share

14 mai 2025, 23:10 UTC

Résultats

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth -- Update

14 mai 2025, 23:07 UTC

Résultats

CoreWeave Posts Strong Revenue and Wins Google as a Customer. Stock Still Dives on Outlook. -- Barrons.com

14 mai 2025, 23:00 UTC

Actualités

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud -- WSJ

14 mai 2025, 22:43 UTC

Résultats

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth

14 mai 2025, 22:34 UTC

Résultats

Xero Expects 1H Operating Expense Ratio to Be Higher Than 2H>XRO.AU

14 mai 2025, 22:33 UTC

Résultats

Xero Expects FY26 Operating Expense Ratio of 71.5%>XRO.AU

14 mai 2025, 22:30 UTC

Résultats

Xero Did Not Declare a Dividend>XRO.AU

14 mai 2025, 22:30 UTC

Résultats

Xero FY Operating Expenses 71.8% of Operating Revenue Vs. 73.3%>XRO.AU

14 mai 2025, 22:30 UTC

Résultats

Xero FY Free Cashflow Margin 24.1% Vs. 20.0%>XRO.AU

14 mai 2025, 22:30 UTC

Résultats

Xero FY Free Cashflow NZD506.7M Vs. NZD342.1M>XRO.AU

14 mai 2025, 22:28 UTC

Résultats

Xero FY Ebitda NZD638.5M Vs. NZD497.4M>XRO.AU

14 mai 2025, 22:28 UTC

Résultats

Xero FY Adjusted Ebitda NZD640.6M Vs. NZD526.5M>XRO.AU

14 mai 2025, 22:27 UTC

Résultats

Xero FY Rev NZD2.10B Vs. NZD1.71B >XRO.AU

14 mai 2025, 22:27 UTC

Résultats

Xero FY Net NZD227.8M Vs. Net NZD174.6M >XRO.AU

14 mai 2025, 22:23 UTC

Actualités

Boeing, GE Aerospace Get Qatar Airways Order After Saudi AI Tech Deals -- 2nd Update

14 mai 2025, 22:15 UTC

Résultats

Correction to Cisco Earnings Article -- WSJ

14 mai 2025, 21:48 UTC

Résultats

CoreWeave Posts Strong Revenue but Stock Dives on Updated Outlook -- Barrons.com

14 mai 2025, 21:37 UTC

Résultats

Cisco Reports Solid Earnings. The Stock Is Rising. -- Barrons.com

Comparaison

Variation de prix

Vitrolife AB prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.